Use of Electronic Medical Records in Oncology Outcomes Research

Overview

Journal Clinicoecon Outcomes Res

Publisher Dove Medical Press

Specialty Health Services

Date 2011 Sep 22

PMID 21935310

Citations 14

Authors

Gena Kanas

Libby Morimoto

Fionna Mowat

Cynthia OMalley

Jon Fryzek

Robert Nordyke

Affiliations

Soon will be listed here.

Abstract

Oncology outcomes research could benefit from the use of an oncology-specific electronic medical record (EMR) network. The benefits and challenges of using EMR in general health research have been investigated; however, the utility of EMR for oncology outcomes research has not been explored. Compared to current available oncology databases and registries, an oncology-specific EMR could provide comprehensive and accurate information on clinical diagnoses, personal and medical histories, planned and actual treatment regimens, and post-treatment outcomes, to address research questions from patients, policy makers, the pharmaceutical industry, and clinicians/researchers. Specific challenges related to structural (eg, interoperability, data format/entry), clinical (eg, maintenance and continuity of records, variety of coding schemes), and research-related (eg, missing data, generalizability, privacy) issues must be addressed when building an oncology-specific EMR system. Researchers should engage with medical professional groups to guide development of EMR systems that would ultimately help improve the quality of cancer care through oncology outcomes research.

Citing Articles

Continuous multimodal data supply chain and expandable clinical decision support for oncology.

Chang J, Kim H, Baek E, Choi J, Lim J, Kim J NPJ Digit Med. 2025; 8(1):128.

PMID: 40016534 PMC: 11868524. DOI: 10.1038/s41746-025-01508-2.

Electronic health records and patient registries in medical oncology departments in Spain.

Ribelles N, Alvarez-Lopez I, Arcusa A, Chacon J, de la Haba J, Garcia-Corbacho J Clin Transl Oncol. 2021; 23(10):2099-2108.

PMID: 33864619 PMC: 8390424. DOI: 10.1007/s12094-021-02614-9.

Nutrition Information in Oncology - Extending the Electronic Patient-Record Data Set.

Maranhao P, Pereira A, Calhau C, Ravasco P, Bozzetti F, Laviano A J Med Syst. 2020; 44(11):191.

PMID: 32986139 PMC: 7520877. DOI: 10.1007/s10916-020-01649-9.

Facts and figures on medical record management from a multi super specialty hospital in Delhi NCR: A descriptive analysis.

Verma S, Midha M, Bhadoria A J Family Med Prim Care. 2020; 9(1):418-423.

PMID: 32110629 PMC: 7014864. DOI: 10.4103/jfmpc.jfmpc_612_19.

Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study.

Wanat M, Wang X, Paranjpe R, Chen H, Johnson M, Fleming M Res Pract Thromb Haemost. 2019; 3(4):674-683.

PMID: 31624787 PMC: 6781914. DOI: 10.1002/rth2.12221.

References

Ambinder E . Electronic health records. J Oncol Pract. 2010; 1(2):57-63. PMC: 2793588. DOI: 10.1200/JOP.2005.1.2.57. View

National Quality Measures Clearinghouse , Agency For Healthcare Research And Quality . Imaging studies for low back pain. J Pain Palliat Care Pharmacother. 2011; 22(4):306-11. DOI: 10.1080/15360280802537332. View

Dean B, Lam J, Natoli J, Butler Q, Aguilar D, Nordyke R . Review: use of electronic medical records for health outcomes research: a literature review. Med Care Res Rev. 2009; 66(6):611-38. DOI: 10.1177/1077558709332440. View

Hayrinen K, Saranto K, Nykanen P . Definition, structure, content, use and impacts of electronic health records: a review of the research literature. Int J Med Inform. 2007; 77(5):291-304. DOI: 10.1016/j.ijmedinf.2007.09.001. View

Cleator S, Heller W, Coombes R . Triple-negative breast cancer: therapeutic options. Lancet Oncol. 2007; 8(3):235-44. DOI: 10.1016/S1470-2045(07)70074-8. View

Schmier J, Halpern M . Patient recall and recall bias of health state and health status. Expert Rev Pharmacoecon Outcomes Res. 2009; 4(2):159-63. DOI: 10.1586/14737167.4.2.159. View

Detmer D, Bloomrosen M, Raymond B, Tang P . Integrated personal health records: transformative tools for consumer-centric care. BMC Med Inform Decis Mak. 2008; 8:45. PMC: 2596104. DOI: 10.1186/1472-6947-8-45. View

Slattery M, Anderson K, Samowitz W, Edwards S, Curtin K, Caan B . Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control. 1999; 10(5):467-73. DOI: 10.1023/a:1008974215622. View

Galligioni E, Berloffa F, Caffo O, Tonazzolli G, Ambrosini G, Valduga F . Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience. Ann Oncol. 2008; 20(2):349-52. DOI: 10.1093/annonc/mdn567. View

10.

Bidard F, Conforti R, Boulet T, Michiels S, Delaloge S, Andre F . Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers. Ann Oncol. 2007; 18(7):1285-6. DOI: 10.1093/annonc/mdm360. View

11.

Thakkar M, Davis D . Risks, barriers, and benefits of EHR systems: a comparative study based on size of hospital. Perspect Health Inf Manag. 2007; 3:5. PMC: 2047303. View

12.

Gross C, Smith B, Wolf E, Andersen M . Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002?. Cancer. 2008; 112(4):900-8. PMC: 3535295. DOI: 10.1002/cncr.23228. View

13.

Lisovicz N, Wynn T, Fouad M, Partridge E . Cancer health disparities: what we have done. Am J Med Sci. 2008; 335(4):254-9. PMC: 3230119. DOI: 10.1097/maj.0b013e31816a43ad. View

14.

Pakhomov S, Weston S, Jacobsen S, Chute C, Meverden R, Roger V . Electronic medical records for clinical research: application to the identification of heart failure. Am J Manag Care. 2007; 13(6 Part 1):281-8. View

15.

Carey L, Perou C, Livasy C, Dressler L, Cowan D, Conway K . Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295(21):2492-502. DOI: 10.1001/jama.295.21.2492. View

16.

Kim M, Ro J, Ahn S, Kim H, Kim S, Gong G . Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol. 2006; 37(9):1217-26. DOI: 10.1016/j.humpath.2006.04.015. View

17.

Burt C, Sisk J . Which physicians and practices are using electronic medical records?. Health Aff (Millwood). 2005; 24(5):1334-43. DOI: 10.1377/hlthaff.24.5.1334. View

18.

Osoba D . Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol. 1994; 12(3):608-16. DOI: 10.1200/JCO.1994.12.3.608. View

19.

Sorlie T, Perou C, Fan C, Geisler S, Aas T, Nobel A . Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Mol Cancer Ther. 2006; 5(11):2914-8. DOI: 10.1158/1535-7163.MCT-06-0126. View

20.

Donovan K, Greene P, Shuster J, Partridge E, Tucker D . Treatment preferences in recurrent ovarian cancer. Gynecol Oncol. 2002; 86(2):200-11. DOI: 10.1006/gyno.2002.6748. View